CL stock forecast, quote, news & analysis

Key Takeaways

• Colgate-Palmolive shares closed at $90.75 on July 24, 2026, reflecting a modest decline of roughly 1.4% over the past 30 days, consistent with the stock's low-beta, defensive profile.
• The company remains a Dividend King with 64 consecutive years of dividend increases and uninterrupted payouts dating back to 1895; the quarterly dividend stands at $0.53 per share, yielding approximately 2.3%.
• Analysts maintain a consensus "Moderate Buy" rating with an average 12-month price target near $97.82, though individual targets range from $85 to $110, reflecting divergent views on margin trajectory and valuation.
• Q2 2026 earnings are scheduled for release on July 31, with consensus estimates calling for EPS of $0.95 on revenue of approximately $5.35 billion.
• Margin pressures from elevated raw material and logistics costs — management flagged roughly $300 million in incremental inflationary headwinds for 2026 — remain the dominant near-term concern for investors.

Current Market Snapshot

Colgate-Palmolive shares have traded in a relatively narrow range in recent weeks, hovering near the stock's 50-day moving average of approximately $90.77 and its 200-day moving average near $89.05. With a beta of just 0.33, CL has historically exhibited far lower volatility than the broader market. The stock currently sits roughly 9% below its 52-week high of $99.33 and well above its 52-week low of $74.54. Trading at a forward price-to-earnings ratio of roughly 23.5, CL commands a premium relative to the household products industry average, reflecting investor confidence in the company's pricing power, global brand portfolio, and consistent earnings execution. Institutional ownership remains concentrated at roughly 80.4%, with notable recent activity including Sei Investments Co. increasing its stake by nearly 40% during the first quarter.

Colgate-Palmolive (CL) Business Overview and Competitive Position

Colgate-Palmolive Company is a global consumer products leader operating across four core segments: Oral Care, Personal Care, Home Care, and Pet Nutrition. The company sells products in more than 200 countries and territories under brands including Colgate, Palmolive, Ajax, Softsoap, Irish Spring, Speed Stick, Tom's of Maine, and Hill's Science Diet. Hill's Pet Nutrition accounts for approximately 23% of total company sales and remains a differentiated growth engine supported by science-based formulations and strong veterinary endorsements. Colgate's geographic footprint is heavily weighted toward emerging markets — combined sales from Latin America, Asia Pacific, Europe, and Africa/Eurasia far exceed North American revenue — providing a natural hedge against U.S.-specific economic headwinds. The company's leadership in global toothpaste market share, premiumization strategy in oral care, and investments in AI-driven marketing and supply chain efficiency further reinforce its competitive moat.

Recent Developments Driving CL

Several analyst firms updated their positions on Colgate-Palmolive in mid-July. JPMorgan raised its price target from $96 to $104 with an "overweight" rating, while Citigroup lifted its target from $105 to $110, both citing confidence in the company's emerging-market momentum and pricing power. UBS raised its target to $106 while maintaining a "buy" rating. On the more cautious side, Barclays raised its target from $80 to $87 but kept an "equal weight" rating, noting valuation concerns. The company declared a regular quarterly dividend of $0.53 per share in June, payable on August 14 to shareholders of record as of July 20. The ex-dividend date has now passed. On the operational front, management continues to execute its Strategic Growth & Productivity Program, which is expected to generate $200 million to $300 million in savings, with the majority of benefits flowing in 2027 and 2028. Inflation remains a headwind — Colgate is modeling oil at roughly $110 per barrel for the remainder of 2026, with oil-byproduct costs up more than 20% year-over-year and logistics expenses up roughly 10%.

Trending AI Robots

For traders seeking data-driven insights beyond traditional analysis, Tickeron's Trending AI Robots page offers a curated view of the platform's top-performing AI-powered trading bots. Tickeron hosts hundreds of bots that collectively trade thousands of tickers across multiple strategies, timeframes, and performance profiles. Only the most relevant and consistently high-performing bots appear in the Trending section, helping users filter through the noise to identify strategies aligned with current market conditions. Whether a trader favors short-term momentum signals or longer-duration swing strategies, the Trending AI Robots page provides a snapshot of what is working now. Exploring this section can offer a useful complement to fundamental research when evaluating stocks like Colgate-Palmolive.

2026 Outlook and What Investors Should Watch

The most immediate catalyst for Colgate-Palmolive is the Q2 2026 earnings report on July 31. Investors will closely scrutinize organic sales growth trends — especially in North America, where Q1 net sales declined 1.8% amid delayed product launches and heightened promotional competition. Margin performance will be equally critical, given management's revised guidance for year-over-year gross margin contraction driven by roughly $300 million in incremental raw material and logistics costs. The pace of recovery in private-label pet food — the exit from which created an approximately 260-basis-point headwind — will also be in focus, with management expecting normalization in the second half of the year. Beyond earnings season, key macro variables include commodity price trajectories, global tariff developments, currency fluctuations in emerging markets, and the broader consumer spending environment. Colgate's ability to sustain volume growth while navigating cost pressures through pricing, productivity programs, and revenue growth management will likely define the stock's trajectory through year-end.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations